These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5325145)

  • 1. The effect of atropine in the management of early fulminant meningococcemia.
    Ouyang HM; Huang CY; Mei JL; Ch'ai CC; Shao HY; Wu HC
    Chin Med J; 1965 Jul; 84(7):427-32. PubMed ID: 5325145
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoproterenol in the treatment of fulminating meningococcemia in children complicated by shock. An analysis of 181 cases].
    Liu YL
    Zhonghua Yi Xue Za Zhi; 1974; (12):766-70, 214. PubMed ID: 4217259
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia.
    Zenz W; Muntean W; Gallistl S; Zobel G; Grubbauer HM
    Pediatrics; 1995 Jul; 96(1 Pt 1):144-8. PubMed ID: 7596694
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock.
    Leclerc F; Cremer R; Leteurtre S; Martinot A; Fourier C
    Crit Care Med; 2000 May; 28(5):1694-7. PubMed ID: 10834762
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone in fulminant meningococcemia.
    Cocchi P; Silenzi M; Calabri G; Salvi G
    Pediatr Infect Dis; 1984; 3(2):187. PubMed ID: 6728708
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
    Zenz W; Muntean W; Zobel G; Grubbauer HM; Gallistl S
    Thromb Haemost; 1995 Aug; 74(2):802-3. PubMed ID: 8585030
    [No Abstract]   [Full Text] [Related]  

  • 7. Should steroids be used in children with meningococcal shock?
    Branco RG; Russell RR
    Arch Dis Child; 2005 Nov; 90(11):1195-6. PubMed ID: 16243881
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock.
    Michel F; Thomachot L; David M; Nicaise C; Vialet R; Di Marco JN; Lagier P; Martin C
    Am J Emerg Med; 2007 Sep; 25(7):863.e1-2. PubMed ID: 17870513
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated protein C for the treatment of fulminant meningococcal septicaemia.
    Thomas GL; Wigmore T; Clark P
    Anaesth Intensive Care; 2004 Apr; 32(2):284-7. PubMed ID: 15957734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal membrane oxygenation for refractory shock in fulminant meningococcal sepsis.
    Champion MP; Murdoch IA; Sajjanhar T; Marsh MJ
    Lancet; 1996 Jan; 347(8995):201-2. PubMed ID: 8544579
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningococcal septic shock: is insulin lifesaving in children?
    Mormile R; De Michele M
    Int J Infect Dis; 2011 Jul; 15(7):e504. PubMed ID: 21530349
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic improvement in a child with meningococcal sepsis following methylprednisolone: restoration of beta-adrenergic receptor responsiveness?
    O'Brien K; Morton NS
    Paediatr Anaesth; 1998; 8(5):419-20. PubMed ID: 9742538
    [No Abstract]   [Full Text] [Related]  

  • 13. Once daily ceftriaxone for meningococcemia and meningococcal meningitis.
    Tuncer AM; Gür I; Ertem U; Ece A; Türkmen S; Deniz B; Gürman I; Tuncer S
    Pediatr Infect Dis J; 1988 Oct; 7(10):711-3. PubMed ID: 3054778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.
    Derkx B; Wittes J; McCloskey R
    Clin Infect Dis; 1999 Apr; 28(4):770-7. PubMed ID: 10825037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with activated protein C for meningococcal septic shock: case report and literature review.
    Hasin T; Leibowitz D; Rot D; Weiss Y; Chajek-Shaul T; Nir-Paz R
    Intensive Care Med; 2005 Jul; 31(7):1002-3. PubMed ID: 15905995
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of heparin in the treatment of meningococcal purpura fulminans. 3 cases].
    Charlas J; Thieffry JC; Madelin JC; Dardenne P; Meyer B; Paupe J; Vialatte J
    Ann Pediatr (Paris); 1970; 17(8):553-9. PubMed ID: 5455263
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on "Early treatment with activated protein C for meningococcal septic shock: case report and literature review" by Hasin et al.
    Thomas GL; Clark P
    Intensive Care Med; 2005 Dec; 31(12):1729; author reply 1730. PubMed ID: 16283165
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolyte therapy of septicemic shock in infancy and childhood].
    Mitterstieler G; Kurz R; Waltl H; Berger H
    Padiatr Padol; 1973; 8(2):225-31. PubMed ID: 4698436
    [No Abstract]   [Full Text] [Related]  

  • 19. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
    Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S
    J Infect Dis; 1995 Jan; 171(1):229-32. PubMed ID: 7798670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin therapy in fulminant meningococcemia.
    Najjar SS; Ahmad M
    J Pediatr; 1969 Sep; 75(3):449-53. PubMed ID: 5804192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.